Rectifying function, restoring hope
Developing disease-modifying precision therapeutics for patients with serious genetic diseases
About us
Rectify is developing Positive Functional Modulators (PFMs), disease-modifying precision therapeutics that restore ABC transporter function for patients with serious genetic diseases.
ABC transporters are a 48-member family of membrane-bound proteins with etiologic loss-of-function mutations in multiple organ systems and therapeutic areas including the lungs, liver, gastrointestinal tract, eye, and central nervous system.
Our team
Leadership
Rajesh Devraj, Ph.D.
President and Chief Executive Officer
Jonathan Moore, Ph.D.
Founder and Chief Scientific Officer
Tracey Dawson, Ph.D.
Chief Operating Officer
Janeta Popovici-Muller, Ph.D.
Senior Vice President, Head of Drug Discovery
Alastair Garfield, Ph.D.
Senior Vice President, Head of Biology
Scientific Advisory Board
Richard Chesworth, DPhil
Independent R&D Consultant
Bob Copeland, Ph.D.
Co-Founder and CSO, Accent Therapeutics
Richard Thompson, BM BCh, DM
Professor of Molecular Hepatology, School of Immunology & Microbial Sciences at King’s College London
Jamie Williamson, Ph.D.
Professor, Department of Integrative Structural and Computational Biology, Scripps Research Institute
Board of Directors
Jason Rhodes
Executive Chairman, Partner, Atlas Venture
Rajesh Devraj, Ph.D.
President and CEO, Rectify Pharmaceuticals
Marco Boorsma, Ph.D.
General Partner, Forbion
Jonathan Moore, Ph.D.
Founder and CSO, Rectify Pharmaceuticals
Otello Stampacchia, Ph.D.
Founder and Managing Partner, Omega Funds
David Steinberg, MBA
General Partner, Longwood Fund
Jodie Morrison
Venture Partner, Atlas Venture
Investors
Join us
We are a team of passionate, driven scientists and biotech leaders, united in our vision to restore hope to individuals and families affected by serious genetic disease.
Rectify Pharma is looking for motivated individuals to join our growing team. Please click here to see our current openings or email careers@rectifypharma.com for more information.
